Denise R Aberle

Professor, Radiological Sciences, University of California Los Angeles

(310) 794-8996

UC Profile

Education and Training

UCSF School of Medicine1986Thoracic Imaging Fellowship
UCLA School of Medicine1985Chest | Body Imaging Fellowship
UCLA School of Medicine1985Diagnostic Radiology, Residency
Boston University1982Internal Medicine, Residency
University of Kansas Medical Center1980Internal Medicine-Internship
University of Kansas Medical CenterMD1979Medicine
University of KansasBA1975French Literature

Awards and Honors

  • Special Recognition Award for Outstanding Contribution to Lung Cancer Screening, International Association for the Study of Lung Cancer, 2011.
  • Joseph W. Cullen Prevention/Early Detection Award for Lifeline Achievement in the Prevention of Lung, International Association for the Study of Lung Cancer, 2019.
  • Outstanding Leadership in Thoracic Radiology, Society of Thoracic Radiology, 2011.
  • Lung Force IMPACT Award, American Lung Association, 2014.
  • Elected Member, California Academy of Bioengineering, 2021.
  • Los Angeles Top Doctors, Los Angeles Magazie, 2014-2021.
  • Certificate of Outstanding Contribution, American College of Radiology Imaging Network, 2002.
  • Fellow, American Institute for Medical and Biomedical Engineering (AIMBE), 2017.
  • Council of Distinguished Investigators, Academy of Radiology Research, 2012.
  • Certificate of Outstanding Contribution, American College of Radiology Imaging Network, 2007.
  • Lifetime Achievemet (Gold Medal) Award, Society of Thoracic Radiology, 2015.
  • Inaugural Geoffrey McLennan Visiting Lectureship in Pulmonary Disease and Biomedical Imaging, University of Iowa | Department of Medicine, 2012.
  • Leo G. Rigler Outstanding Teaching Award, UCLA Radiological Sciences, 1998.
  • CTSI Award for Outstandig Achievement in Clinical and Translatioal Research, UCLA Clinical and Translational Science Institute, 2011.
  • Elected Member, National Academy of Medicine, 2019.
  • Certificate of Outstanding Contribution, American College of Radiology Imaging Network, 2001.

Publications

  1. Christensen J, Prosper AE, Wu CC, Chung J, Lee E, Elicker B, Hunsaker AR, Petranovic M, Sandler KL, Stiles B, Mazzone P, Yankelevitz D, Aberle D, Chiles C, Kazerooni E. ACR Lung-RADS v2022: Assessment Categories and Management Recommendations.. Chest, 2024.
  2. Milch HS, Luhar A, Manning B, Aberle DR, Sayre J, Moriarty JM. Teach the Mentor: A Six-Session Program Universally Improves Mentorship Skills Among a Diverse Group of Radiology Faculty.. Journal of the American College of Radiology : JACR, 2024.
  3. Robertson SE, Joyce NR, Steingrimsson JA, Stuart EA, Aberle DR, Gatsonis CA, Dahabreh IJ. Comparing Lung Cancer Screening Strategies in a Nationally Representative US Population Using Transportability Methods for the National Lung Cancer Screening Trial.. JAMA network open, 2024.
  4. Christensen J, Prosper AE, Wu CC, Chung J, Lee E, Elicker B, Hunsaker AR, Petranovic M, Sandler KL, Stiles B, Mazzone P, Yankelevitz D, Aberle D, Chiles C, Kazerooni E. ACR Lung-RADS v2022: Assessment Categories and Management Recommendations.. Journal of the American College of Radiology : JACR, 2023.
  5. Yanagawa J, Tran LM, Salehi-Rad R, Lim RJ, Dumitras C, Fung E, Wallace WD, Prosper AE, Fishbein G, Shea C, Hong R, Kahangi B, Deng JJ, Gower AC, Liu B, Campbell JD, Mazzilli SA, Beane JE, Kadara H, Lenburg ME, Spira AE, Aberle DR, Krysan K, Dubinett SM. Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma.. Cancer research, 2023.
  6. Prosper AE, Kammer MN, Maldonado F, Aberle DR, Hsu W. Expanding Role of Advanced Image Analysis in CT-detected Indeterminate Pulmonary Nodules and Early Lung Cancer Characterization.. Radiology, 2023.
  7. Batool SM, Yekula A, Khanna P, Hsia T, Gamblin AS, Ekanayake E, Escobedo AK, You DG, Castro CM, Im H, Kilic T, Garlin MA, Skog J, Dinulescu DM, Dudley J, Agrawal N, Cheng J, Abtin F, Aberle DR, Chia D, Elashoff D, Grognan T, Krysan K, Oh SS, Strom C, Tu M, Wei F, Xian RR, Skates SJ, Zhang DY, Trinh T, Watson M, Aft R, Rawal S, Agarwal A, Kesmodel SB, Yang C, Shen C, Hochberg FH, Wong DTW, Patel AA, Papadopoulos N, Bettegowda C, Cote RJ, Srivastava S, Lee H, Carter BS, Balaj L. The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring.. Cell reports. Medicine, 2023.
  8. Li S, Zeng W, Ni X, Liu Q, Li W, Stackpole ML, Zhou Y, Gower A, Krysan K, Ahuja P, Lu DS, Raman SS, Hsu W, Aberle DR, Magyar CE, French SW, Han SB, Garon EB, Agopian VG, Wong WH, Dubinett SM, Zhou XJ. Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring.. Proceedings of the National Academy of Sciences of the United States of America, 2023.
  9. Lin Y, Liang LJ, Ding R, Prosper AE, Aberle DR, Hsu W. Factors Associated With Nonadherence to Lung Cancer Screening Across Multiple Screening Time Points.. JAMA network open, 2023.
  10. Lin Y, Ding R, Prosper AE, Aberle DR, Bui AAT, Hsu W. Capturing Demographic, Health-Related, and Psychosocial Variables in a Standardized Manner: Towards Improving Cancer Screening Adherence.. AMIA ... Annual Symposium proceedings. AMIA Symposium, 2023.
  11. Xu K, Diaz AA, Duan F, Lee M, Xiao X, Liu H, Liu G, Cho MH, Gower AC, Alekseyev YO, Spira A, Aberle DR, Washko GR, Billatos E, Lenburg ME, DECAMP investigators. Bronchial gene expression alterations associated with radiological bronchiectasis.. The European respiratory journal, 2023.
  12. Stackpole ML, Zeng W, Li S, Liu CC, Zhou Y, He S, Yeh A, Wang Z, Sun F, Li Q, Yuan Z, Yildirim A, Chen PJ, Winograd P, Tran B, Lee YT, Li PS, Noor Z, Yokomizo M, Ahuja P, Zhu Y, Tseng HR, Tomlinson JS, Garon E, French S, Magyar CE, Dry S, Lajonchere C, Geschwind D, Choi G, Saab S, Alber F, Wong WH, Dubinett SM, Aberle DR, Agopian V, Han SB, Ni X, Li W, Zhou XJ. Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer.. Nature communications, 2022.
  13. Wood DE, Kazerooni EA, Aberle D, Berman A, Brown LM, Eapen GA, Ettinger DS, Ferguson JS, Hou L, Kadaria D, Klippenstein D, Kumar R, Lackner RP, Leard LE, Lennes IT, Leung ANC, Mazzone P, Merritt RE, Midthun DE, Onaitis M, Pipavath S, Pratt C, Puri V, Raz D, Reddy C, Reid ME, Sandler KL, Sands J, Schabath MB, Studts JL, Tanoue L, Tong BC, Travis WD, Wei B, Westover K, Yang SC, McCullough B, Hughes M. NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022.. Journal of the National Comprehensive Cancer Network : JNCCN, 2022.
  14. Lin Y, Fu M, Ding R, Inoue K, Jeon CY, Hsu W, Aberle DR, Prosper AE. Patient Adherence to Lung CT Screening Reporting & Data System-Recommended Screening Intervals in the United States: A Systematic Review and Meta-Analysis.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021.
  15. Inoue K, Hsu W, Arah OA, Prosper AE, Aberle DR, Bui AAT. Generalizability and Transportability of the National Lung Screening Trial Data: Extending Trial Results to Different Populations.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2021.
  16. Prosper AE, Inoue K, Brown K, Bui AAT, Aberle D, Hsu W. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.. JAMA network open, 2021.
  17. Kinsey CM, Billatos E, Mori V, Tonelli B, Cole BF, Duan F, Marques H, de la Bruere I, Onieva J, San José Estépar R, Cleveland A, Idelkope D, Stevenson C, Bates JHT, Aberle D, Spira A, Washko G, San José Estépar R. A simple assessment of lung nodule location for reduction in unnecessary invasive procedures.. Journal of thoracic disease, 2021.
  18. Smedley NF, Aberle DR, Hsu W. Using deep neural networks and interpretability methods to identify gene expression patterns that predict radiomic features and histology in non-small cell lung cancer.. Journal of medical imaging (Bellingham, Wash.), 2021.
  19. Hopkins RJ, Duan F, Gamble GD, Chiles C, Cavadino A, Billings P, Aberle D, Young RP. Chr15q25 genetic variant (rs16969968) independently confers risk of lung cancer, COPD and smoking intensity in a prospective study of high-risk smokers.. Thorax, 2021.
  20. Gould MK, Altman DE, Creekmur B, Qi L, de Bie E, Golden S, Kaplan CP, Kelly K, Miglioretti DL, Mularski RA, Musigdilok VV, Smith-Bindman R, Steltz JP, Wiener RS, Aberle DR, Dyer DS, Vachani A. Guidelines for the Evaluation of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Awareness, Agreement, and Adherence From the Watch the Spot Trial.. Journal of the American College of Radiology : JACR, 2020.
  21. Billatos E, Ash SY, Duan F, Xu K, Romanoff J, Marques H, Moses E, Han MK, Regan EA, Bowler RP, Mason SE, Doyle TJ, San José Estépar R, Rosas IO, Ross JC, Xiao X, Liu H, Liu G, Sukumar G, Wilkerson M, Dalgard C, Stevenson C, Whitney D, Aberle D, Spira A, San José Estépar R, Lenburg ME, Washko GR, DECAMP and COPDGene Investigators. Distinguishing Smoking-Related Lung Disease Phenotypes Via Imaging and Molecular Features.. Chest, 2020.
  22. Prosper A, Brown K, Schussel B, Aberle D. Lung Cancer Screening in African Americans: The Time to Act Is Now.. Radiology. Imaging cancer, 2020.
  23. Lin Y, Wei L, Han SX, Aberle DR, Hsu W. EDICNet: An end-to-end detection and interpretable malignancy classification network for pulmonary nodules in computed tomography.. Proceedings of SPIE--the International Society for Optical Engineering, 2020.
  24. Brown MS, Lo P, Goldin JG, Barnoy E, Kim GHJ, McNitt-Gray MF, Aberle DR. Correction to: Toward clinically usable CAD for lung cancer screening with computed tomography.. European radiology, 2020.
  25. Schabath MB, Aberle DR. MILD trial, strong confirmation of lung cancer screening efficacy.. Nature reviews. Clinical oncology, 2019.
  26. Petousis P, Winter A, Speier W, Aberle DR, Hsu W, Bui AAT. Using Sequential Decision Making to Improve Lung Cancer Screening Performance.. IEEE access : practical innovations, open solutions, 2019.
  27. Munden RF, Chiles C, Boiselle PM, Sicks JD, Aberle DR, Gatsonis CA. Micronodules Detected on Computed Tomography During the National Lung Screening Trial: Prevalence and Relation to Positive Studies and Lung Cancer.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2019.
  28. Krysan K, Tran LM, Grimes BS, Fishbein GA, Seki A, Gardner BK, Walser TC, Salehi-Rad R, Yanagawa J, Lee JM, Sharma S, Aberle DR, Spira AE, Elashoff DA, Wallace WD, Fishbein MC, Dubinett SM. The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy.. Cancer research, 2019.
  29. Winter A, Aberle DR, Hsu W. External validation and recalibration of the Brock model to predict probability of cancer in pulmonary nodules using NLST data.. Thorax, 2019.
  30. Billatos E, Duan F, Moses E, Marques H, Mahon I, Dymond L, Apgar C, Aberle D, Washko G, Spira A, DECAMP investigators. Detection of early lung cancer among military personnel (DECAMP) consortium: study protocols.. BMC pulmonary medicine, 2019.
  31. Shen S, Han SX, Aberle DR, Bui AA, Hsu W. An Interpretable Deep Hierarchical Semantic Convolutional Neural Network for Lung Nodule Malignancy Classification.. Expert systems with applications, 2019.
  32. Scafoglio CR, Villegas B, Abdelhady G, Bailey ST, Liu J, Shirali AS, Wallace WD, Magyar CE, Grogan TR, Elashoff D, Walser T, Yanagawa J, Aberle DR, Barrio JR, Dubinett SM, Shackelford DB. Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma.. Science translational medicine, 2018.
  33. Garcia-Gathright JI, Matiasz NJ, Adame C, Sarma KV, Sauer L, Smedley NF, Spiegel ML, Strunck J, Garon EB, Taira RK, Aberle DR, Bui AAT. Evaluating Casama: Contextualized semantic maps for summarization of lung cancer studies.. Computers in biology and medicine, 2017.
  34. Hopkins RJ, Duan F, Chiles C, Greco EM, Gamble GD, Aberle D, Young RP. Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.. Annals of the American Thoracic Society, 2017.
  35. Aberle DR. Implementing lung cancer screening: the US experience.. Clinical radiology, 2017.
  36. Gierada DS, Pinsky PF, Duan F, Garg K, Hart EM, Kazerooni EA, Nath H, Watts JR, Aberle DR. Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants.. European radiology, 2017.
  37. Barjaktarevic I, Arenberg D, Grimes BS, Ruchalski K, Aberle DR. Indeterminate Pulmonary Nodules: How to Minimize Harm.. Seminars in respiratory and critical care medicine, 2016.
  38. Schabath MB, Massion PP, Thompson ZJ, Eschrich SA, Balagurunathan Y, Goldof D, Aberle DR, Gillies RJ. Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.. PloS one, 2016.
  39. Petousis P, Han SX, Aberle D, Bui AA. Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network.. Artificial intelligence in medicine, 2016.
  40. Zide M, Caswell K, Peterson E, Aberle DR, Bui AA, Arnold CW. Consumers' Patient Portal Preferences and Health Literacy: A Survey Using Crowdsourcing.. JMIR research protocols, 2016.
  41. Garcia-Gathright JI, Matiasz NJ, Garon EB, Aberle DR, Taira RK, Bui AAT. Toward patient-tailored summarization of lung cancer literature.. ... IEEE-EMBS International Conference on Biomedical and Health Informatics. IEEE-EMBS International Conference on Biomedical and Health Informatics, 2016.
  42. Patz EF, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.. The Lancet. Oncology, 2016.
  43. Young RP, Duan F, Chiles C, Hopkins RJ, Gamble GD, Greco EM, Gatsonis C, Aberle D. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.. American journal of respiratory and critical care medicine, 2015.
  44. Arnold CW, Wallace WD, Chen S, Oh A, Abtin F, Genshaft S, Binder S, Aberle D, Enzmann D. RadPath: A Web-based System for Integrating and Correlating Radiology and Pathology Findings During Cancer Diagnosis.. Academic radiology, 2015.
  45. McNamara M, Arnold C, Sarma K, Aberle D, Garon E, Bui AA. Patient Portal Preferences: Perspectives on Imaging Information.. Journal of the Association for Information Science and Technology, 2015.
  46. Weber WA, Gatsonis CA, Mozley PD, Hanna LG, Shields AF, Aberle DR, Govindan R, Torigian DA, Karp JS, Yu JQ, Subramaniam RM, Halvorsen RA, Siegel BA, ACRIN 6678 Research team, MK-0646-008 Research team. Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015.
  47. Pinsky PF, Gierada DS, Black W, Munden R, Nath H, Aberle D, Kazerooni E. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.. Annals of internal medicine, 2015.
  48. Oh AS, Arnold CW, Vangala S, Wallace WD, Genshaft SJ, Sarma K, Aberle DR. Imaging-histologic discordance at percutaneous biopsy of the lung.. Academic radiology, 2015.
  49. Garcia-Gathright JI, Oh A, Abarca PA, Han M, Sago W, Spiegel ML, Wolf B, Garon EB, Bui AA, Aberle DR. Representing and extracting lung cancer study metadata: study objective and study design.. Computers in biology and medicine, 2015.
  50. McNamara M, Sarma K, Aberle DR, Bui AA, Arnold C. Data model for personalized patient health guidelines: an exploratory study.. AMIA ... Annual Symposium proceedings. AMIA Symposium, 2014.
  51. Black WC, Gareen IF, Soneji SS, Sicks JD, Keeler EB, Aberle DR, Naeim A, Church TR, Silvestri GA, Gorelick J, Gatsonis C, National Lung Screening Trial Research Team. Cost-effectiveness of CT screening in the National Lung Screening Trial.. The New England journal of medicine, 2014.
  52. Gierada DS, Pinsky P, Nath H, Chiles C, Duan F, Aberle DR. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.. Journal of the National Cancer Institute, 2014.
  53. Brown MS, Lo P, Goldin JG, Barnoy E, Kim GH, McNitt-Gray MF, Aberle DR. Toward clinically usable CAD for lung cancer screening with computed tomography.. European radiology, 2014.
  54. Patz EF, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR, NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer.. JAMA internal medicine, 2014.
  55. Field JK, Aberle DR, Altorki N, Baldwin DR, Dresler C, Duffy SW, Goldstraw P, Hirsch FR, Pedersen JH, de Koning HJ, Mulshine JL, Sullivan DC, Tsao MS, Travis WD, International Association for the Study of Lung Cancer Strategic Screening Advisory Committee. The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014.
  56. Shih YC, Ganz PA, Aberle D, Abernethy A, Bekelman J, Brawley O, Goodwin JS, Hu JC, Schrag D, Temel JS, Schnipper L. Delivering high-quality and affordable care throughout the cancer care continuum.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013.
  57. Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J, National Lung Screening Trial Research Team. Results of the two incidence screenings in the National Lung Screening Trial.. The New England journal of medicine, 2013.
  58. Bui AA, Hsu W, Arnold C, El-Saden S, Aberle DR, Taira RK. Imaging-based observational databases for clinical problem solving: the role of informatics.. Journal of the American Medical Informatics Association : JAMIA, 2013.
  59. National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gierada DS, Jones GC, Mahon I, Marcus PM, Sicks JD, Jain A, Baum S. Results of initial low-dose computed tomographic screening for lung cancer.. The New England journal of medicine, 2013.
  60. Aberle DR, Abtin F, Brown K. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013.
  61. Austin JH, Garg K, Aberle D, Yankelevitz D, Kuriyama K, Lee HJ, Brambilla E, Travis WD. Radiologic implications of the 2011 classification of adenocarcinoma of the lung.. Radiology, 2012.
  62. Sorace J, Aberle DR, Elimam D, Lawvere S, Tawfik O, Wallace WD. Integrating pathology and radiology disciplines: an emerging opportunity?. BMC medicine, 2012.
  63. Aberle DR, Henschke CI, McLoud TC, Boiselle PM. Expert opinion: barriers to CT screening for lung cancer.. Journal of thoracic imaging, 2012.
  64. Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, Pedersen JH, Swanson SJ, Travis WD, Wisbuba II, Noguchi M, Mulshine JL, IASLC CT Screening Workshop 2011 Participants. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012.
  65. Berg CD, Aberle DR, Wood DE. Lung cancer screening: promise and pitfalls.. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2012.
  66. Marcus PM, Gareen IF, Miller AB, Rosenbaum J, Keating K, Aberle DR, Berg CD. The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death.. Contemporary clinical trials, 2011.
  67. Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D. Lung cancer chemoprevention with celecoxib in former smokers.. Cancer prevention research (Philadelphia, Pa.), 2011.
  68. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening.. The New England journal of medicine, 2011.
  69. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M, Yankelewitz D. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2011.
  70. Armato SG, McLennan G, Bidaut L, McNitt-Gray MF, Meyer CR, Reeves AP, Zhao B, Aberle DR, Henschke CI, Hoffman EA, Kazerooni EA, MacMahon H, Van Beeke EJ, Yankelevitz D, Biancardi AM, Bland PH, Brown MS, Engelmann RM, Laderach GE, Max D, Pais RC, Qing DP, Roberts RY, Smith AR, Starkey A, Batrah P, Caligiuri P, Farooqi A, Gladish GW, Jude CM, Munden RF, Petkovska I, Quint LE, Schwartz LH, Sundaram B, Dodd LE, Fenimore C, Gur D, Petrick N, Freymann J, Kirby J, Hughes B, Casteele AV, Gupte S, Sallamm M, Heath MD, Kuhn MH, Dharaiya E, Burns R, Fryd DS, Salganicoff M, Anand V, Shreter U, Vastagh S, Croft BY. The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): a completed reference database of lung nodules on CT scans.. Medical physics, 2011.
  71. Duda C, Mahon I, Chen MH, Snyder B, Barr R, Chiles C, Falk R, Fishman EK, Gemmel D, Goldin JG, Brown K, Munden RF, Vydareny K, Aberle DR. Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.. Clinical trials (London, England), 2011.
  72. Kramer BS, Berg CD, Aberle DR, Prorok PC. Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST).. Journal of medical screening, 2011.
  73. National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, Lynch DA, Marcus PM, Pinsky PF. Baseline characteristics of participants in the randomized national lung screening trial.. Journal of the National Cancer Institute, 2010.
  74. National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ. The National Lung Screening Trial: overview and study design.. Radiology, 2010.
  75. Patz EF, Caporaso NE, Dubinett SM, Massion PP, Hirsch FR, Minna JD, Gatsonis C, Duan F, Adams A, Apgar C, Medina RM, Aberle DR. National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010.
  76. Boiselle PM, Aberle DR, Bankier AA, de Roos A, Gefter WB, Goodman L, Grenier P, Hansell DM, Herold CJ, Im JG, Johkoh T, Kauczor HU, Kazerooni E, Kono M, Levin DC, MacMahon H, McLoud TC, Miller SW, Müller NL, Naidich DP, Prince MR, Rémy-Jardin MR, Schoepf UJ, Stillman AE, Webb WR, White CS. 25-on-25: twenty-five perspectives on twenty-five years of cardiopulmonary imaging. Part III.. Journal of thoracic imaging, 2010.
  77. Boiselle PM, Aberle DR, Bankier AA, de Roos A, Gefter WB, Goodman L, Grenier P, Hansell DM, Herold CJ, Im JG, Johkoh T, Kauczor HU, Kazerooni E, Kono M, Levin DC, MacMahon H, McLoud TC, Miller SW, Müller NL, Naidich DP, Prince MR, Rémy-Jardin MR, Schoepf UJ, Stillman AE, Webb WR, White CS. 25-on-25: twenty-five perspectives on twenty-five years of cardiopulmonary imaging.. Journal of thoracic imaging, 2010.
  78. Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R. National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.. Journal of the National Cancer Institute, 2010.
  79. Allegra CJ, Aberle DR, Ganschow P, Hahn SM, Lee CN, Millon-Underwood S, Pike MC, Reed SD, Saftlas AF, Scarvalone SA, Schwartz AM, Slomski C, Yothers G, Zon R. NIH state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ (DCIS).. NIH consensus and state-of-the-science statements, 2009.
  80. Armato SG, Roberts RY, Kocherginsky M, Aberle DR, Kazerooni EA, Macmahon H, van Beek EJ, Yankelevitz D, McLennan G, McNitt-Gray MF, Meyer CR, Reeves AP, Caligiuri P, Quint LE, Sundaram B, Croft BY, Clarke LP. Assessment of radiologist performance in the detection of lung nodules: dependence on the definition of "truth".. Academic radiology, 2009.
  81. Dubinett SM, Aberle DR, Tashkin DP, Mao JT. The partners--airflow obstruction, emphysema, and lung cancer.. American journal of respiratory and critical care medicine, 2008.
  82. Aberle DR, Brown K. Lung cancer screening with CT.. Clinics in chest medicine, 2008.
  83. McNitt-Gray MF, Armato SG, Meyer CR, Reeves AP, McLennan G, Pais RC, Freymann J, Brown MS, Engelmann RM, Bland PH, Laderach GE, Piker C, Guo J, Towfic Z, Qing DP, Yankelevitz DF, Aberle DR, van Beek EJ, MacMahon H, Kazerooni EA, Croft BY, Clarke LP. The Lung Image Database Consortium (LIDC) data collection process for nodule detection and annotation.. Academic radiology, 2007.
  84. Reeves AP, Biancardi AM, Apanasovich TV, Meyer CR, MacMahon H, van Beek EJ, Kazerooni EA, Yankelevitz D, McNitt-Gray MF, McLennan G, Armato SG, Henschke CI, Aberle DR, Croft BY, Clarke LP. The Lung Image Database Consortium (LIDC): a comparison of different size metrics for pulmonary nodule measurements.. Academic radiology, 2007.
  85. Armato SG, Roberts RY, McNitt-Gray MF, Meyer CR, Reeves AP, McLennan G, Engelmann RM, Bland PH, Aberle DR, Kazerooni EA, MacMahon H, van Beek EJ, Yankelevitz D, Croft BY, Clarke LP. The Lung Image Database Consortium (LIDC): ensuring the integrity of expert-defined "truth".. Academic radiology, 2007.
  86. Armato SG, McNitt-Gray MF, Reeves AP, Meyer CR, McLennan G, Aberle DR, Kazerooni EA, MacMahon H, van Beek EJ, Yankelevitz D, Hoffman EA, Henschke CI, Roberts RY, Brown MS, Engelmann RM, Pais RC, Piker CW, Qing D, Kocherginsky M, Croft BY, Clarke LP. The Lung Image Database Consortium (LIDC): an evaluation of radiologist variability in the identification of lung nodules on CT scans.. Academic radiology, 2007.
  87. Berg CD, Aberle DR. Computed tomography screening for lung cancer.. JAMA, 2007.
  88. Krishnam MS, Suh RD, Tomasian A, Goldin JG, Lai C, Brown K, Batra P, Aberle DR. Postoperative complications of lung transplantation: radiologic findings along a time continuum.. Radiographics : a review publication of the Radiological Society of North America, Inc, 2007.
  89. Bui AA, Aberle DR, Kangarloo H. TimeLine: visualizing integrated patient records.. IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society, 2007.
  90. Brown MS, Pais R, Qing P, Shah S, McNitt-Gray MF, Goldin JG, Petkovska I, Tran L, Aberle DR. An architecture for computer-aided detection and radiologic measurement of lung nodules in clinical trials.. Cancer informatics, 2007.
  91. Black WC, Aberle DR, Berg CD. Large field trial for lung cancer screening: putting the wrong cart before the horse?. Radiology, 2007.
  92. Brown MS, McNitt-Gray MF, Pais R, Shah SK, Qing P, Da Costa I, Aberle DR, Goldin JG. CAD in clinical trials: current role and architectural requirements.. Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society, 2007.
  93. Petkovska I, Brown MS, Goldin JG, Kim HJ, McNitt-Gray MF, Abtin FG, Ghurabi RJ, Aberle DR. The effect of lung volume on nodule size on CT.. Academic radiology, 2007.
  94. Berg CD, Aberle DR, National Lung Screening Trial Executive Committee. CT screening for lung cancer.. The New England journal of medicine, 2007.
  95. Bui AA, Morioka C, Dionisio JD, Johnson DB, Sinha U, Ardekani S, Taira RK, Aberle DR, El-Saden S, Kangarloo H. OpenSourcePACS: an extensible infrastructure for medical image management.. IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society, 2007.
  96. Cagnon CH, Cody DD, McNitt-Gray MF, Seibert JA, Judy PF, Aberle DR. Description and implementation of a quality control program in an imaging-based clinical trial.. Academic radiology, 2006.
  97. Gandara DR, Aberle D, Lau D, Jett J, Akhurst T, Heelan R, Mulshine J, Berg C, Patz EF. Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2006.
  98. Meyer CR, Johnson TD, McLennan G, Aberle DR, Kazerooni EA, Macmahon H, Mullan BF, Yankelevitz DF, van Beek EJ, Armato SG, McNitt-Gray MF, Reeves AP, Gur D, Henschke CI, Hoffman EA, Bland PH, Laderach G, Pais R, Qing D, Piker C, Guo J, Starkey A, Max D, Croft BY, Clarke LP. Evaluation of lung MDCT nodule annotation across radiologists and methods.. Academic radiology, 2006.
  99. Petkovska I, Shah SK, McNitt-Gray MF, Goldin JG, Brown MS, Kim HJ, Brown K, Aberle DR. Pulmonary nodule characterization: a comparison of conventional with quantitative and visual semi-quantitative analyses using contrast enhancement maps.. European journal of radiology, 2006.
  100. Aberle DR. Perspective on the STR consensus statement.. Journal of thoracic imaging, 2005.
  101. Sheehan R, Perloff JK, Fishbein MC, Gjertson D, Aberle DR. Pulmonary neovascularity: a distinctive radiographic finding in Eisenmenger syndrome.. Circulation, 2005.
  102. Shah SK, McNitt-Gray MF, Rogers SR, Goldin JG, Suh RD, Sayre JW, Petkovska I, Kim HJ, Aberle DR. Computer aided characterization of the solitary pulmonary nodule using volumetric and contrast enhancement features.. Academic radiology, 2005.
  103. Brown MS, Goldin JG, Rogers S, Kim HJ, Suh RD, McNitt-Gray MF, Shah SK, Truong D, Brown K, Sayre JW, Gjertson DW, Batra P, Aberle DR. Computer-aided lung nodule detection in CT: results of large-scale observer test.. Academic radiology, 2005.
  104. Aberle DR, Chiles C, Gatsonis C, Hillman BJ, Johnson CD, McClennan BL, Mitchell DG, Pisano ED, Schnall MD, Sorensen AG, American College of Radiology Imaging Network. Imaging and cancer: research strategy of the American College of Radiology Imaging Network.. Radiology, 2005.
  105. Shah SK, McNitt-Gray MF, Rogers SR, Goldin JG, Suh RD, Sayre JW, Petkovska I, Kim HJ, Aberle DR. Computer-aided diagnosis of the solitary pulmonary nodule.. Academic radiology, 2005.
  106. Shah SK, McNitt-Gray MF, De Zoysa KR, Sayre JW, Kim HJ, Batra P, Behrashi A, Brown K, Greaser LE, Park JM, Roback DK, Wu C, Zaragoza E, Goldin JG, Suh RD, Brown MS, Aberle DR. Solitary pulmonary nodule diagnosis on CT: results of an observer study.. Academic radiology, 2005.
  107. Brown MS, Shah SK, Pais RC, Lee YZ, McNitt-Gray MF, Goldin JG, Cardenas AF, Aberle DR. Database design and implementation for quantitative image analysis research.. IEEE transactions on information technology in biomedicine : a publication of the IEEE Engineering in Medicine and Biology Society, 2005.
  108. Tran LN, Brown MS, Goldin JG, Yan X, Pais RC, McNitt-Gray MF, Gjertson D, Rogers SR, Aberle DR. Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography.. Academic radiology, 2004.
  109. Armato SG, McLennan G, McNitt-Gray MF, Meyer CR, Yankelevitz D, Aberle DR, Henschke CI, Hoffman EA, Kazerooni EA, MacMahon H, Reeves AP, Croft BY, Clarke LP, Lung Image Database Consortium Research Group. Lung image database consortium: developing a resource for the medical imaging research community.. Radiology, 2004.
  110. Bui AA, Taira RK, El-Saden S, Dordoni A, Aberle DR. Automated medical problem list generation: towards a patient timeline.. Studies in health technology and informatics, 2004.
  111. Bui AA, Taira RK, Goldman D, Dionisio JD, Aberle DR, El-Saden S, Sayre J, Rice T, Kangarloo H. Effect of an imaging-based streamlined electronic healthcare process on quality and costs.. Academic radiology, 2004.
  112. Brown MS, Goldin JG, Suh RD, McNitt-Gray MF, Sayre JW, Aberle DR. Lung micronodules: automated method for detection at thin-section CT--initial experience.. Radiology, 2003.
  113. Bui AA, Taira RK, Dionisio JD, Aberle DR, El-Saden S, Kangarloo H. Evidence-based radiology: requirements for electronic access.. Academic radiology, 2002.